Celgene (CELG) Tops Q3 EPS by 10c; Boosts FY16 EPS Outlook

October 27, 2016 7:31 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Celgene (NASDAQ: CELG) reported Q3 EPS of $1.58, $0.10 better than the analyst estimate of $1.48. Revenue was $2.97 billion, versus $2.83 billion expected.


Celgene sees FY2016 EPS of $5.88 - $5.92, versus prior guidance of $5.70 - $5.75 and the consensus of $5.77.

For earnings history and earnings-related data on Celgene (CELG) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities


Add Your Comment